ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Last Issue Until Aug. 20

July 30, 1982

Obey Erred On Criticism Of Pap Test Cost, FCRC Construction

August 10, 1979

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

In Brief: Saunders Retires As Dean of UT Graduate School At Galveston; Started Centers Program At NCI

August 21, 1987

Specific Pathology Pattern Can Predict Recurrence

August 30, 2013

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

April 27, 2007